Adverse Event Analysis

In the recent years, people have become largely dependent on the healing benefits of therapeutic drugs, thereby challenging manufacturers to keep up with the increasing demand for new drugs and remedies. Thorough scientific testing during the pre-market phase of a new drug would not completely disclose its side effects. This is because many drugs would have potential, serious, and unidentified side effects during their primary advent into the drug market. It is at this juncture that the FDA’s AERS plays an essential role in tracking adverse drug reactions.

We carry out an exhaustive, all-inclusive, and comprehensive analysis on drugs that have reported adverse reactions and outcomes associated with them in the AERS database. In so doing, we are able to help improve standards of medical therapeutics.